AI-Native Naming Intelligence for Pharmaceutical Regulatory Teams
LexiAI screens and generates compliant drug brand names — with a patent-pending mechanism that prevents regulatory conflicts at the point of generation, not after. The first module in a broader regulatory intelligence platform.
8 Naming Disciplines
From INN stems to commercial brands — every naming challenge in pharma and medtech, covered.
INN / USAN
International nonproprietary name compliance
Brand / Product
Commercial brand name generation
Corporate
Corporate entity naming
Clinical Trial
Study and protocol naming
Portfolio
Product portfolio architecture
Tagline
Regulatory-safe tagline creation
Linguistic
Cross-cultural name validation
Trademark
Trademark conflict screening
How It Works
From intake to submission dossier in three steps.
Configure Your Run
Select discipline, define product profile, choose target markets, and set creativity parameters.
AI Generates & Screens
Our 7-engine regulatory stack analyzes phonetics, trademarks, linguistics, and market readiness in real time.
Review & Submit
Compare candidates side-by-side, download regulatory dossiers, and submit with confidence.
The LexiAI Regulatory Intelligence Platform
Naming Intelligence is live today. It's the first of eight modules planned across the regulatory lifecycle — Regulatory Change Intelligence, Labeling Intelligence, Safety Intelligence, Submission Intelligence, Regulatory Precedent Intelligence, Regulatory Portfolio Intelligence, and a Regulatory Knowledge Copilot. We're building deep in naming first, not wide across all eight — depth before breadth.